- Report
- March 2026
- 200 Pages
Global
From €2487EUR$2,789USD£2,131GBP
- Report
- August 2026
- 110 Pages
Global
From €4235EUR$4,750USD£3,630GBP
- Report
- August 2026
- 180 Pages
Global
From €4235EUR$4,750USD£3,630GBP
- Report
- July 2026
- 110 Pages
Global
From €4235EUR$4,750USD£3,630GBP
- Report
- June 2026
- 110 Pages
Global
From €4235EUR$4,750USD£3,630GBP
- Report
- April 2026
- 180 Pages
Global
From €4235EUR$4,750USD£3,630GBP
- Report
- April 2026
- 70 Pages
Global
From €4235EUR$4,750USD£3,630GBP
- Report
- August 2026
- 309 Pages
Global
From €2229EUR$2,500USD£1,910GBP
- Report
- August 2026
- 307 Pages
Global
From €2229EUR$2,500USD£1,910GBP
- Report
- August 2026
- 337 Pages
Global
From €2229EUR$2,500USD£1,910GBP
- Report
- August 2026
- 296 Pages
Global
From €2229EUR$2,500USD£1,910GBP
- Report
- May 2026
- 304 Pages
Global
From €2229EUR$2,500USD£1,910GBP
- Report
- May 2026
- 333 Pages
Global
From €2229EUR$2,500USD£1,910GBP
- Report
- April 2026
- 286 Pages
Global
From €2229EUR$2,500USD£1,910GBP
- Report
- January 2026
- 291 Pages
Global
From €2229EUR$2,500USD£1,910GBP
- Report
- January 2026
- 280 Pages
Global
From €2229EUR$2,500USD£1,910GBP
- Report
- June 2026
- 149 Pages
Global
From €2674EUR$2,999USD£2,292GBP
€3565EUR$3,999USD£3,056GBP
- Report
- May 2026
- 138 Pages
Global
From €2674EUR$2,999USD£2,292GBP
€3565EUR$3,999USD£3,056GBP
- Report
- May 2026
- 137 Pages
Global
From €2674EUR$2,999USD£2,292GBP
€3565EUR$3,999USD£3,056GBP
- Report
- May 2026
- 149 Pages
Global
From €2674EUR$2,999USD£2,292GBP
€3565EUR$3,999USD£3,056GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more